Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Skin Disease in Rheumatology Patients Should Prompt Collaboration with Dermatologists

Vanessa Caceres  |  Issue: March 2015  |  March 1, 2015

However, the dermatologists interviewed for this article would prefer to see rheumatologists stick to the lower potency therapies, due to the possible side effects with the higher potencies. “There are times to use the high potency steroids, but that should be done under the close watch of a dermatologist,” says dermatologist Delphine Lee, MD, PhD, director of translational immunology, Dirks/Dougherty Laboratory for Cancer Research, the John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, Calif.

“Use the stronger steroids for a shorter period of time, or the less strong ones for longer,” recommends rheumatologist Nathan Wei, MD, The Arthritis Treatment Center, Frederick, Md.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Wei’s approach will depend on the extent of skin disease. If it’s a psoriatic arthritis patient with significant disease, he will always ask an area dermatologist to help recommend treatment. He also sticks to short durations for any use of a topical steroid on the face.

Rheumatologists should be sure to give a sufficient amount of topical steroid when writing prescriptions, Dr. Merola advised. “I remind people that 20 to 30 grams is around the size of a travel-sized toothpaste. Use that as a reference, and then you can scale up if needed,” he says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Physicians also have to consider the body surface area of involvement, frequency of use and duration of use in prescribing an adequate amount of steroid. “A safe mantra to teach the patient is to use the topical steroid for two weeks and then take one week off,” Dr. Merola says. “This reduces the risk of skin atrophy.”

Dr. Frankel also prefers a maximum use of two weeks on the body, but a maximum of one week if the use is on the face.

Avoid the use of fluorinated steroids on the face, cautions Dr. Ross. Topicals with fluorination can cause rashes on the face because they are too strong.

Although topical steroids have fewer side effects than their systemic counterparts, there are still a number of cautions to consider, especially as the potency increases. Some side effects include acne, thinning of the skin and redness, Dr. Lee says.

Other risks include cataracts, the formation of new blood vessels, tachyphylaxis (which is a decrease in response to topical corticosteroids when they are used constantly), Cushing’s syndrome, stretch marks, steroid rosacea, warts, viral infections and increased susceptibility to skin infections, Dr. Frankel says. And if a topical steroid is unintentionally used in an area with skin cancer, that could delay diagnosis, Dr. Frankel adds.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsPractice Support Tagged with:Dermatologyrheumatologistskin diseaseSteroidTreatment

Related Articles

    7 Tips That Dermatologists Want Rheumatologists to Know

    November 2, 2014

    Recommendations on diagnosing, treating health conditions that cross over both specialties

    What Rheumatologists Wish Their Colleagues Knew: Managing Skin Disease & Comorbidities

    March 3, 2017

    From treating rashes to uncovering a case of osteoarthritis, dermatologists and rheumatologists can work together in a variety of ways to improve patient care, says Joseph F. Merola, MD, MMSc…

    Challenges in Psoriatic Arthritis

    November 29, 2022

    PHILADELPHIA—Despite a large and ever-growing number of therapeutic options for our patients with psoriatic disease, it is not uncommon for us come across scenarios in which a patient’s response to therapy does not match our expectations and our shared goals for treatment. We all have those patients—the ones whose joints improve with one drug, but…

    2015 ACR/ARHP Annual Meeting: Skin Issues in Rheumatic Diseases Present Challenges

    March 15, 2016

    SAN FRANCISCO—A 40-year-old woman shows up in the clinic with scarring alopecia, with an area of hyperpigmentation on the rim of her scalp, extending from just behind the temple to behind her ears. An examination with a dermatoscope shows hyperkeratotic follicular plugging. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEThe case—in this example, the discoid form of cutaneous…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences